0001019056-21-000147.txt : 20210217 0001019056-21-000147.hdr.sgml : 20210217 20210217210329 ACCESSION NUMBER: 0001019056-21-000147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210129 FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Marvin L CENTRAL INDEX KEY: 0001493324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 21647353 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 white.xml X0306 4 2021-01-29 0 0001671584 Aptevo Therapeutics Inc. APVO 0001493324 White Marvin L C/O APTEVO THERAPEUTICS INC. 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 1 1 0 0 President and CEO Stock Option (right to buy) 33.50 2021-01-29 4 A 0 43125 0 A 2031-01-29 Common Stock 43125 43125 D Restricted Stock Unit 2021-01-29 4 A 0 14375 0 A Common Stock 14375 14375 D The option vests in three approximately equal annual installments beginning on January 29, 2022. Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis. The RSU vests in three approximately equal annual installments beginning on January 29, 2022. /s/ Carl A. Valenstein, attorney-in-fact 2021-02-17